Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Bernat

Bernat Catala Mora, Inca ES

Patent application numberDescriptionPublished
20100253482AUTOMATIC PAYMENT SYSTEM FOR THE URBAN PARKING PHASES OF VEHICLES USING RADIO FREQUENCY (RFID) - An automatic payment system for the urban parking phases of vehicles using radio frequency (RFID), contemplating the implementation of a hybrid card for radio frequency identification (RFID-smartcard) which is installed inside the vehicle, integrated by blocks into which the system, together with the communication protocols used, has been divided, and has a series of buttons and an LCD display for the user to interact with the system without needing any other additional device and in which an ultra high frequency (UHF) RFID tag reader/writer, together with a passive tag adhered thereto, is placed, the objective of which will be to read and write the necessary data on the passive tag, which can in turn be read by an external, portable, neither fixed nor stationary RFID reader.10-07-2010

Bernat Isern Amengual, Palma De Mallorca Baleares ES

Patent application numberDescriptionPublished
20090203650USE OF PHYTATE AS AGENT INHIBITING DISSOLUTION OF CRYSTALS OF CALCIUM SALTS FOR THE PREVENTION OF OSTEOPOROSIS - The present invention relates to the use of myo-inositol hexaphosphate or a pharmaceutically acceptable salt thereof for the manufacture of a medicament for the prevention or treatment of a disease associated with the dissolution of crystals of calcium salts, in particular osteoporosis. These compounds may be utilized in the manufacture of functional foods, dietetic supplements, vitamin supplements, nutritional supplements, food supplements, or phytotherapeutic products having properties of inhibition of dissolution of crystals of calcium salts.08-13-2009

Bernat Isern Amengual, Consell ES

Patent application numberDescriptionPublished
20090035232FIXED-DOSE ASSOCIATION OF PHYTATE AND ZINC - The invention relates to a fixed-dose association of 5 phytate and zinc in synergic proportions for use in the treatment of crystallisation of hydroxyapatite. Advantageously, said association is in a molar ratio between the phytate and the zinc exceeding 4:1. The invention also relates to the use of said 10 association for manufacturing a drug for the treatment, prophylaxis and/or prevention crystallisation of hydroxyapatite in humans.02-05-2009

Bernat Sales Lopez, Sabadell (barcelona) ES

Patent application numberDescriptionPublished
20100106825METHOD AND SYSTEM FOR MANAGING RELATED-PATIENT PARAMETERS PROVIDED BY A MONITORING DEVICE04-29-2010